Each year, about 400,000 people die as a result of diseases transmitted by unsafe injections. Yet, over 16 billion unsafe injections are still in use in developing countries.


At ADMD, we use technology to innovate a range of healthcare products that address some of these critical issues. Our flagship Auto Disable (AD) syringe comes with a fixed needle that can be used just once. It uses a three-part assembly which forms a unique one way valve. The valve gets activated after the first usage, blocking further intake of liquid and preventing refill.


The Auto Disable mechanism effectively eliminates the risk of patient-to-patient infection via blood borne pathogens such as HIV or Hepatitis B. The three major global health policy bodies, the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF) and the United Nations Population Fund (UNFPA) have fully endorsed and implemented the use of AD syringes in all global immunization services as recommended in the WHO-UNICEF-UNFPA Joint Statement of 1999.


The AD syringe is a shining example of our innovation aimed at enhancing patient care and improving healthcare outcomes worldwide.